A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

Trial Profile

A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms PATHOS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 08 Jul 2013 Results of a cost-effectiveness analysis (n=5468) presented at the 9th World Congress of the International Health Economics Association: Celebrating Health Economics.
    • 17 Jun 2013 A second analysis of data was published in the British Medical Journal, according to an AstraZeneca media release.
    • 22 May 2013 Results presented at the 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top